A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease
Clinical trial NCT00265122 · COMPLETED
Trial details
- NCT number
- NCT00265122
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2005-11-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.